Microangiopathic hemolytic anemia as the first manifestation of lung adenocarcinoma.
Anemia is common in patients with disseminated carcinoma and is usually due to bleeding, infection, or marrow suppression from chemotherapy or metastatic infiltration. However, microangiopathic hemolytic anemia is rarely seen in such patients. We report a case in which microangiopathic hemolytic anemia was the initial finding in lung adenocarcinoma.
Polukhin
E
E
Department of Physical Medicine and Rehabilitation, State University of New York at Buffalo, USA.
Balla
A
A
Chary
K
K
Mezhir
J
J
D000230:Adenocarcinoma / Q000150:complications* / Q000473:pathology; D000328:Adult; D000743:Anemia, Hemolytic / Q000209:etiology*; D017809:Fatal Outcome; D006801:Humans; D008175:Lung Neoplasms / Q000150:complications* / Q000473:pathology; D008297:Male; D011655:Pulmonary Embolism / Q000209:etiology; D014057:Tomography, X-Ray Computed